Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer.
暂无分享，去创建一个
S. Cannistra | N. Lindeman | U. Matulonis | G. Fleming | W. Growdon | D. Gulhan | P. Konstantinopoulos | Joyce F. Liu | R. Penson | M. Buss | E. Stover | K. Gray | C. Krasner | S. Campos | S. Hill | W. Luo | A. Gockley | S. Schumer | C. Whalen | J. Ishizuka | J. Curtis | A. Wright | H. Crowe | Roxanne Quinn